A phase 1 dose-escalation study of the poly(ADP-ribose) polymerase inhibitor senaparib in Australian patients with advanced solid tumors

Gao, B; Voskoboynik, M; Cooper, A; Wilkinson, K; Hoon, S; Hsieh, CY; Cai, SX; Tian, YE; Bao, J; Ma, N; Wang, C; Zhang, M; Li, BY; Guo, MC; Zhou, RY; Wang, XZ; Xu, C; de Souza, P

de Souza, P (通讯作者)，St George Private Hosp, Med Oncol, Suite 5,Level 4,1 South St, Kogarah, NSW 2217, Australia.

CANCER, 2023; 129 (7): 1041

Abstract

BackgroundSenaparib is a novel, selective poly(ADP-ribose) polymerase-1/2 inhibitor with strong antitumor activity in preclinical studies. This first-......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索